Difference between revisions of "Team:EPF Lausanne/Judging"

Line 143: Line 143:
 
                   <tr class="evenb">
 
                   <tr class="evenb">
 
                       <td>Document at least one new standard BioBrick Part or Device central to your project and submit this part to the iGEM Registry</td>
 
                       <td>Document at least one new standard BioBrick Part or Device central to your project and submit this part to the iGEM Registry</td>
−
  <td>For S. cerevisiae we created new BioBiobriks. In particular the dCas9 fused with the VP64 RNA polymerase subunit and different synthetic gRNAs.</td>
+
  <td>For S. cerevisiae we created new BioBricks. They consists on dCas9 fused with the VP64 RNA polymerase subunit and different synthetic gRNAs.</td>
−
                       <td><a href="http://parts.igem.org/Part:BBa_K1723021">BBa_K1723021</a></br>
+
                       <td><a href="http://parts.igem.org/Part:BBa_K1723021" target="blank">BBa_K1723021</a></br>
−
  <a href="http://parts.igem.org/Part:BBa_K1723009">BBa_K1723009</a></br>
+
  <a href="http://parts.igem.org/Part:BBa_K1723009" target="blank">BBa_K1723009</a></br>
−
  <a href="http://parts.igem.org/Part:BBa_K1723010">BBa_K1723010</a></br>
+
  <a href="http://parts.igem.org/Part:BBa_K1723010" target="blank">BBa_K1723010</a></br>
−
  <a href="http://parts.igem.org/Part:BBa_K1723011">BBa_K1723011</a></br>
+
  <a href="http://parts.igem.org/Part:BBa_K1723011" target="blank">BBa_K1723011</a></br>
−
  <a href="http://parts.igem.org/Part:BBa_K1723012">BBa_K1723012</a></br>
+
  <a href="http://parts.igem.org/Part:BBa_K1723012" target="blank">BBa_K1723012</a></br>
−
  <a href="http://parts.igem.org/Part:BBa_K1723013">BBa_K1723013</a></br>
+
  <a href="http://parts.igem.org/Part:BBa_K1723013" target="blank">BBa_K1723013</a></br>
−
   <a href="http://parts.igem.org/Part:BBa_K1723014">BBa_K1723014</a></br>
+
   <a href="http://parts.igem.org/Part:BBa_K1723014" target="blank">BBa_K1723014</a></br>
−
<a href="http://parts.igem.org/Part:BBa_K1723015">BBa_K1723015</a></br>
+
<a href="http://parts.igem.org/Part:BBa_K1723015" target="blank">BBa_K1723015</a></br>
−
<a href="http://parts.igem.org/Part:BBa_K1723016">BBa_K1723016</a></br>
+
<a href="http://parts.igem.org/Part:BBa_K1723016" target="blank">BBa_K1723016</a></br>
−
<a href="http://parts.igem.org/Part:BBa_K1723017">BBa_K1723017</a></br>
+
<a href="http://parts.igem.org/Part:BBa_K1723017" target="blank">BBa_K1723017</a></br>
−
<a href="http://parts.igem.org/Part:BBa_K1723018">BBa_K1723018</a></br>
+
<a href="http://parts.igem.org/Part:BBa_K1723018" target="blank">BBa_K1723018</a></br>
−
<a href="http://parts.igem.org/Part:BBa_K1723019">BBa_K1723019</a></br>
+
<a href="http://parts.igem.org/Part:BBa_K1723019" target="blank">BBa_K1723019</a></br>
−
<a href="http://parts.igem.org/Part:BBa_K1723020">BBa_K1723020</a></td>
+
<a href="http://parts.igem.org/Part:BBa_K1723020" target="blank">BBa_K1723020</a></td>
 
                   </tr>
 
                   </tr>
  
Line 176: Line 176:
 
                   <tr class="s">
 
                   <tr class="s">
 
                       <td>Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected. </td>
 
                       <td>Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected. </td>
−
                       <td></td>
+
                       <td>For E. coli we created new BioBricks and we were able to test them experimentally (cf. our <a href="https://2015.igem.org/Team:EPF_Lausanne/Results" target="blank">Results</a> page). </td>
−
  <td></td>
+
  <td><a href="http://parts.igem.org/Part:BBa_K1723000" target="blank">BBa_K1723000</a></br>
 +
  <a href="http://parts.igem.org/Part:BBa_K1723005" target="blank">BBa_K1723005</a></br>
 +
  <a href="http://parts.igem.org/Part:BBa_K1723002" target="blank">BBa_K1723002</a></br>
 +
  <a href="http://parts.igem.org/Part:BBa_K1723003" target="blank">BBa_K1723003</a></br>
 +
  <a href="http://parts.igem.org/Part:BBa_K1723004" target="blank">BBa_K1723004</a></br>
 +
  <a href="http://parts.igem.org/Part:BBa_K1723006" target="blank">BBa_K1723006</a></br>
 +
  <a href="http://parts.igem.org/Part:BBa_K1723007" target="blank">BBa_K1723007</a></br>
 +
  <a href="http://parts.igem.org/Part:BBa_K1723008" target="blank">BBa_K1723008</a></br>
 +
  </td>
 
                   </tr>
 
                   </tr>
  
Line 188: Line 196:
 
                   <tr class="s">
 
                   <tr class="s">
 
                       <td>iGEM projects involve important questions beyond the bench. Demonstrate how your team has identified, investigated and addressed one or more of these questions in the context of your project.</td>
 
                       <td>iGEM projects involve important questions beyond the bench. Demonstrate how your team has identified, investigated and addressed one or more of these questions in the context of your project.</td>
−
  <td>Cas9/dCas9 is a new tool for genome editing/regulation. It is so easy to use and so powerful that his discovery reopen the debate over GMO and synthetic biology in general. We adressed the ethical issue of OGM by interviewing experts of different fields (professors of biology, professors of ethics, exponents of different religions, ...) and writing an article resuming their viewpoints.</td>
+
  <td></td>
 
                       <td><a href="https://2015.igem.org/Team:EPF_Lausanne/Practices" target="blank">Practices</a></td>
 
                       <td><a href="https://2015.igem.org/Team:EPF_Lausanne/Practices" target="blank">Practices</a></td>
 
                   </tr>
 
                   </tr>
Line 208: Line 216:
 
                   <tr class="g">
 
                   <tr class="g">
 
                       <td>Expand on your silver medal Human Practices activity or demonstrate an innovative Human Practices activity that relates to your project.</td>
 
                       <td>Expand on your silver medal Human Practices activity or demonstrate an innovative Human Practices activity that relates to your project.</td>
−
  <td>Since we belive in the importance of iGEM's human practices or within science in general, we decided to both expand our silver medal Human Practices to the genral public: we performed surveys on GMO in different swiss cities and in some high school classes. In addition we invited two high school classes to a day fill of activities related to synthetic biology.</td>
+
  <td></td>
 
                       <td><a href="https://2015.igem.org/Team:EPF_Lausanne/Practices" target="blank">Practices</a></td>
 
                       <td><a href="https://2015.igem.org/Team:EPF_Lausanne/Practices" target="blank">Practices</a></td>
 
                   </tr>
 
                   </tr>

Revision as of 20:08, 16 September 2015

EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits

Judging

Take a look at our judging form for more details!

Medal criteria

Bronze medal

Criterion Description Link
Register for iGEM, have a great summer, and attend the Giant Jamboree. The team from EPFL (Ecole Polythencique Fédérale de Lausanne) is successful registered to iGEM, the premiere student competition in Synthetic Biology. EPF_Lausanne
Complete judging form The judging form helps iGEM judges to find important informations in order to equally evaluate each team. Judging form
Create and share a Description of the team's project using the iGEM wiki. All the work done by the EPFL iGEM team is documented in this website, called Wiki because powered by Mediawiki. Have a look! Wiki
Present a poster and a talk at the iGEM Jamboree. EPFL iGEM team will fly in Boston on Septenber 24 in order to present the project to other teams coming from all around the world and to discuss it with the judges.
Create a page on your team wiki with clear attribution of each aspect of your project. An iGEM team is often composed of several students with different backgrounds and they are helped by PhD students or professors. The work is attributed clearly to each person which contributed to the project. Attributions
Document at least one new standard BioBrick Part or Device central to your project and submit this part to the iGEM Registry For S. cerevisiae we created new BioBricks. They consists on dCas9 fused with the VP64 RNA polymerase subunit and different synthetic gRNAs. BBa_K1723021
BBa_K1723009
BBa_K1723010
BBa_K1723011
BBa_K1723012
BBa_K1723013
BBa_K1723014
BBa_K1723015
BBa_K1723016
BBa_K1723017
BBa_K1723018
BBa_K1723019
BBa_K1723020

Silver medal

Criterion Description Link
Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected. For E. coli we created new BioBricks and we were able to test them experimentally (cf. our Results page). BBa_K1723000
BBa_K1723005
BBa_K1723002
BBa_K1723003
BBa_K1723004
BBa_K1723006
BBa_K1723007
BBa_K1723008
Submit this new part to the iGEM Parts Registry.
iGEM projects involve important questions beyond the bench. Demonstrate how your team has identified, investigated and addressed one or more of these questions in the context of your project. Practices

Gold medal

Criterion Description Link
Expand on your silver medal Human Practices activity or demonstrate an innovative Human Practices activity that relates to your project. Practices
Improve the function or characterization of a previously existing BioBrick Part or Device
Demonstrate a functional prototype of your project.
EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits

NOT PROOFREAD